Tag

Inovio Pharmaceuticals Inc (NASDAQ:INO) announced its DNA vaccine targeting the virulent Middle East Respiratory Syndrome (MERS) induced 100% protection from a live virus challenge in a preclinical study. Patient 80 was still tested positive for the MERS virus as the 35-year-old...

Based on management’s projections and analysis, the Company believes that cash and short-term investments meet its planned working capital requirements through the end of 2018.